C1r/C1s Deficiency

Knowing the Red Flags: Infection and Emergency Care

At a Glance

With C1r/C1s deficiency, a new measured fever or significant chills can signal a rapidly progressing invasive infection. Follow your individualized urgent-care plan and seek immediate help for confusion, stiff neck, breathing trouble, severe headache, or a non-fading rash.

Living with C1r/C1s deficiency means your body lacks a critical first-line defense against “encapsulated” bacteria—germs that wear a protective sugar coating to hide from the immune system ^[1]. While most people use the classical complement pathway to unmask and destroy these bacteria, your system cannot “see” them efficiently ^[2].

Because of this, an infection that might stay localized in another person can become invasive, entering the bloodstream or the lining of the brain ^[3]^[4].

The Important Bacterial Threats

Research shows that patients with classical pathway defects are vulnerable to specific types of bacteria. While these are not the only threats, they are among the most serious examples from limited data:

Streptococcus pneumoniae (Pneumococcus): An important concern for patients with early classical pathway defects, often causing pneumonia, ear infections, or meningitis ^[5]^[3].
Neisseria meningitidis (Meningococcus): Though especially associated with terminal pathway defects, this has been documented in C1s deficiency and can cause life-threatening sepsis and meningitis ^[3]^[6].
Haemophilus influenzae type b (Hib): A cause of severe respiratory and blood infections in those with impaired complement function ^[7].

Emergency Warning Signs: When to Seek Immediate Care

Invasive infections can progress from “feeling a bit off” to a life-threatening crisis very rapidly ^[8]. Do not wait for a rash, a stiff neck, or multiple symptoms to appear. A new measured fever or significant chills should trigger the urgent action in your individualized care plan.

Go to the emergency department immediately or call emergency services if you experience:

Confusion or altered mental state (feeling disoriented or unusually sleepy).
Stiff neck: Difficulty or pain when trying to touch your chin to your chest.
Sudden severe headache accompanied by high fever or sensitivity to light (photophobia).
Nausea and vomiting ^[9]^[10].
Shortness of breath or very rapid breathing ^[11].
Extreme shivering, dizziness, or a feeling of “impending doom.”
A “glass test” rash: A purple or red rash that does not fade when you press a clear glass against it (a sign of bleeding under the skin) ^[12]. (Note: Severe infection can occur without a rash. Do not use the absence of a rash to reassure yourself that sepsis is absent).

Distinguishing “Normal” from “Emergency”

It can be difficult to tell a common viral infection from a major threat. A fever that responds to over-the-counter fever reducers does not rule out a serious invasive illness. Always follow your individualized urgent-care plan for any fever or systemic illness.

Important Note on Vaccination: Being vaccinated or taking preventative antibiotics significantly lowers your risk, but it does not eliminate it ^[13]. You must still seek emergency care for red-flag symptoms even if your vaccines are perfectly up to date ^[13].

At the Emergency Room

When you arrive at the hospital, immediately inform the triage nurse that you have a confirmed classical complement deficiency (C1r/C1s) and are at high risk for invasive encapsulated bacterial infections ^[14].

This information is vital because your written emergency protocol should request urgent clinical assessment and prompt empiric antibiotics when clinically indicated ^[15]^[16]. This ensures doctors do not delay treatment while waiting for cultures, while allowing them to choose the specific antibiotic based on your age, allergies, and local resistance.

Common questions in this guide

Why can a fever be an emergency with C1r/C1s deficiency?

C1r/C1s deficiency can weaken the classical complement pathway, making certain encapsulated bacterial infections more likely to spread beyond their original site. A new measured fever or significant chills should trigger your individualized urgent-care plan, even if a fever reducer lowers the temperature.

Which symptoms mean I should seek emergency care right away?

Seek immediate emergency help for confusion, a stiff neck, a sudden severe headache with high fever or light sensitivity, vomiting, shortness of breath or very rapid breathing, extreme shivering, dizziness, or a purple or red rash that does not fade when pressed. Severe infection can occur without a rash, so do not wait for every warning sign to appear.

Which bacteria are a major concern with C1r/C1s deficiency?

Serious infections may involve Streptococcus pneumoniae, Neisseria meningitidis, or Haemophilus influenzae type b. These bacteria can cause illnesses such as pneumonia, meningitis, sepsis, or severe respiratory and bloodstream infections.

What should I tell the emergency department about my deficiency?

Tell the triage nurse immediately that you have confirmed C1r/C1s classical complement deficiency and are at increased risk for invasive infections caused by encapsulated bacteria. Show your written emergency protocol, which should request urgent assessment and prompt empiric antibiotics when clinically indicated; the treating team will choose medication based on your age, allergies, and local resistance.

Do vaccines eliminate the risk of serious infection with C1r/C1s deficiency?

Ask your healthcare team to review vaccines against pneumococcus, Haemophilus influenzae type b, and both meningococcal groups ACWY and B according to national guidance. Vaccination lowers risk but does not eliminate it, so urgent care is still needed for fever, significant chills, or red-flag symptoms.

Should I take a daily or standby antibiotic for C1r/C1s deficiency?

Whether daily preventive antibiotics or a standby antibiotic is appropriate depends on your medical history and individualized care plan. Ask your healthcare professional for specific instructions, and do not start leftover antibiotics without guidance.

Get notified when new evidence is published on complement component C1r/C1s deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Key takeaways

A new measured fever or significant chills should trigger an individualized urgent-care plan because invasive infection can progress rapidly.
Encapsulated bacteria including Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b can cause serious infection with classical complement deficiency.
Immediate emergency warning signs include confusion, stiff neck, severe headache with fever or light sensitivity, breathing difficulty, or a non-blanching rash.
Tell emergency staff about confirmed C1r/C1s deficiency and show your written protocol so urgent assessment and empiric antibiotics can be considered when clinically indicated.
Vaccines and preventive antibiotics lower infection risk but do not eliminate the need for emergency evaluation when warning signs occur.

References (16)

1
Streptococcus pneumoniae interactions with the complement system.
Gil E, Noursadeghi M, Brown JS
Frontiers in cellular and infection microbiology 2022; (12()):929483 doi:10.3389/fcimb.2022.929483.
PMID: 35967850
2
Complement C1s as a diagnostic marker and therapeutic target: Progress and propective.
Ye J, Yang P, Yang Y, Xia S
Frontiers in immunology 2022; (13()):1015128 doi:10.3389/fimmu.2022.1015128.
PMID: 36275687
3
Complement C1s deficiency in a male Caucasian patient with systemic lupus erythematosus: a case report.
Kleer JS, Skattum L, Dubler D, et al.
Frontiers in immunology 2023; (14()):1257525 doi:10.3389/fimmu.2023.1257525.
PMID: 38469558
4
Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 Patients.
Audemard-Verger A, Descloux E, Ponard D, et al.
Medicine 2016; (95(19)):e3548 doi:10.1097/MD.0000000000003548.
PMID: 27175654
5
Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe.
Turley AJ, Gathmann B, Bangs C, et al.
Journal of clinical immunology 2015; (35(2)):199-205 doi:10.1007/s10875-015-0137-5.
PMID: 25663093
6
Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies.
El Sissy C, Rosain J, Vieira-Martins P, et al.
Frontiers in immunology 2019; (10()):1936 doi:10.3389/fimmu.2019.01936.
PMID: 31440263
7
Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.
Mbaeyi SA, Bozio CH, Duffy J, et al.
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 2020; (69(9)):1-41 doi:10.15585/mmwr.rr6909a1.
PMID: 33417592
8
Complement C5a Receptor 1 Exacerbates the Pathophysiology of N. meningitidis Sepsis and Is a Potential Target for Disease Treatment.
Herrmann JB, Muenstermann M, Strobel L, et al.
mBio 2018; (9(1)) doi:10.1128/mBio.01755-17.
PMID: 29362231
9
Recurrent Pneumococcal Meningitis From Post-traumatic Frontoethmoidal Encephalocele: A Case Report.
Mazen Y, Darweesh A, Al Ani M, et al.
Cureus 2025; (17(12)):e98862 doi:10.7759/cureus.98862.
PMID: 41523552
10
Invasive Non-groupable Meningococcal Disease Complicated by Brain Abscess Revealing C6 Complement Deficiency in a Young Adult.
Caceres-Cardenas G, Bove A, Ortega J, Berger J
Cureus 2026; (18(8)):e114004 doi:10.7759/cureus.114004.
PMID: 42699812
11
Meningococcaemia causing necrotizing cellulitis associated with acquired complement deficiency after gastric bypass surgery: a case report.
Pletschette Z, De Groote E, Mattheus W, et al.
BMC infectious diseases 2020; (20(1)):361 doi:10.1186/s12879-020-05079-3.
PMID: 32434466
12
Invasive Meningococcal Disease in a Patient With Complement 7 Deficiency.
Nishioka H, Maegawa K, Hara S
Journal of general and family medicine 2025; (26(6)):646-649 doi:10.1002/jgf2.70075.
PMID: 41195038
13
Case report: Benefits and challenges of long-term eculizumab in atypical hemolytic uremic syndrome.
Cullinan N, Gorman KM, Riordan M, et al.
Pediatrics 2015; (135(6)):e1506-9 doi:10.1542/peds.2014-3503.
PMID: 25941307
14
European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management.
Brodszki N, Frazer-Abel A, Grumach AS, et al.
Journal of clinical immunology 2020; (40(4)):576-591 doi:10.1007/s10875-020-00754-1.
PMID: 32064578
15
[Reducing the risk of infections in hereditary and acquired complement deficiencies.]
Karászi É, Onozó B, Kulcsár A, et al.
Orvosi hetilap 2023; (164(25)):971-980 doi:10.1556/650.2023.32798.
PMID: 37356020
16
Clinical Outcome and Underlying Genetic Cause of Functional Terminal Complement Pathway Deficiencies in a Multicenter UK Cohort.
Shears A, Steele C, Craig J, et al.
Journal of clinical immunology 2022; (42(3)):665-671 doi:10.1007/s10875-022-01213-9.
PMID: 35084692

This page is for informational purposes only and does not constitute medical advice. It does not replace your individualized emergency plan or urgent assessment by a healthcare professional.